Bryan Bennett

Jazz Pharma

Bryan Bennett is listed at Jazz Pharma. B2DB records 2 sessions at 1 conference in 2026, most recently ISPOR Europe 2026 (November 2026). Speaks mainly at Hospitals and Health Care events.

Compiled from published conference agendas; not yet confirmed by Bryan. Is this you? Claim this profile.

Sector: Hospitals and Health Care

About

Bryan Bennett, PhD, is the Head of Patient-Centered Outcomes and Senior Director at Jazz Pharmaceuticals, where he leads a dedicated team of Outcomes Scientists developing novel Clinical Outcome Assessment (COA) strategies across neuroscience and oncology. With over three decades of experience spanning clinical practice, academia, consultancy, and the pharmaceutical industry, Dr. Bennett is a passionate advocate for patient-focused drug development. He has consistently driven efforts to ensure the patient's voice is integrated into every stage of the therapeutic lifecycle. Dr. Bennett is an active member of the ISPOR community, recently serving on the ISPOR Europe Program Committee and the COA Special Interest Group Leadership team.

Sessions at 1 conference

ISPOR Europe 2026 8 November 2026 – 11 November 2026

COAlescing the Oncology COA Strategy: A Provocative Look at Why Pncology COA Strategies Often Fail - and How to Fix Them Speaker · 9 November 2026
Patient-Centered Evidence Poster Tour Moderator · 9 November 2026

Spoke alongside

People who have shared a session with Bryan at events on B2DB.

Flora Mulkey Food and Drug Administration 1 shared session
Konstantina Skaltsa Senior Director, Research and Scientific Coordinator, Patient-Centered Solutions · Quintiles 1 shared session
Lindsay Hughes IQVIA 1 shared session